HK131293A - Pharmaceutical compositions containing drugs which are sparingly soluble in water or instable and methods for their preparation - Google Patents

Pharmaceutical compositions containing drugs which are sparingly soluble in water or instable and methods for their preparation

Info

Publication number
HK131293A
HK131293A HK1312/93A HK131293A HK131293A HK 131293 A HK131293 A HK 131293A HK 1312/93 A HK1312/93 A HK 1312/93A HK 131293 A HK131293 A HK 131293A HK 131293 A HK131293 A HK 131293A
Authority
HK
Hong Kong
Prior art keywords
instable
water
pharmaceutical compositions
sparingly soluble
preparation
Prior art date
Application number
HK1312/93A
Inventor
Ulrich Brauns
B W W Prof Dr Mueller
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6217510&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK131293(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK131293A publication Critical patent/HK131293A/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Novel pharmaceutical compositions comprise inclusion compounds of drugs, which are instable or only sparingly soluble in water, with partially etherified beta -cyclodextrin derivatives having hydroxyalkyl and optionally additional alkyl groups.
HK1312/93A 1983-12-21 1993-11-25 Pharmaceutical compositions containing drugs which are sparingly soluble in water or instable and methods for their preparation HK131293A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833346123 DE3346123A1 (en) 1983-12-21 1983-12-21 PHARMACEUTICAL PREPARATIONS OF SUBSTANCES MEDICAL OR UNSTABLE IN WATER AND METHOD FOR THE PRODUCTION THEREOF

Publications (1)

Publication Number Publication Date
HK131293A true HK131293A (en) 1993-12-03

Family

ID=6217510

Family Applications (1)

Application Number Title Priority Date Filing Date
HK1312/93A HK131293A (en) 1983-12-21 1993-11-25 Pharmaceutical compositions containing drugs which are sparingly soluble in water or instable and methods for their preparation

Country Status (17)

Country Link
EP (1) EP0149197B2 (en)
JP (1) JPS61500788A (en)
AT (1) ATE51145T1 (en)
AU (1) AU565966B2 (en)
CA (1) CA1222697A (en)
CY (1) CY1689A (en)
DE (2) DE3346123A1 (en)
DK (1) DK175288B1 (en)
FI (1) FI86140C (en)
HK (1) HK131293A (en)
HU (1) HU200943B (en)
LU (1) LU90283I2 (en)
NL (1) NL980009I1 (en)
NO (1) NO2000007I1 (en)
SG (1) SG24893G (en)
WO (1) WO1985002767A1 (en)
ZA (1) ZA8410042B (en)

Families Citing this family (131)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920214A (en) * 1986-04-16 1990-04-24 American Maize-Products Company Process for producing modified cyclodextrins
JPH0819004B2 (en) * 1986-12-26 1996-02-28 日清製粉株式会社 Sustained-release pharmaceutical preparation
IT1203968B (en) * 1987-04-24 1989-02-23 Bononi Ricerca B-CYCLODESTRINE COMPLEXES WITH ANTI-Fungal Activities
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
JP2577049B2 (en) * 1987-06-04 1997-01-29 三共株式会社 Cyclosporine preparation
NZ225045A (en) * 1987-07-01 1990-06-26 Janssen Pharmaceutica Nv Antiviral pharmaceutical compositions containing cyclodextrin and an antiviral agent
ZA884592B (en) * 1987-08-31 1989-03-29 Warner Lambert Co Cyclodextrin complexes of bis-biguanido hexane compounds
US4877774A (en) * 1987-09-09 1989-10-31 The United States Of America As Represented By The Department Of Health And Human Services Administration of steroid hormones
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
DE3843059A1 (en) * 1987-12-22 1989-07-13 Glaxo Group Ltd Aqueous formulations which contain a piperidinylcyclopentylheptenoic acid derivative
US5221695A (en) * 1987-12-22 1993-06-22 Glaxo Group Limited Aqueous formulation containing a piperidinylcyclopentylheptenoic acid derivative and beta-cyclodextrin
US5017566A (en) * 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
ATE74003T1 (en) * 1988-01-14 1992-04-15 Akzo Nv AQUEOUS PHARMACEUTICAL PREPARATION.
US5658894A (en) * 1989-04-23 1997-08-19 The Trustees Of The University Of Pennsylvania Compositions for inhibiting restenosis
US5637575A (en) * 1988-01-19 1997-06-10 The Trustees Of The University Of Pennsylvania Methods of inhibiting restenosis
US5019562A (en) * 1988-01-19 1991-05-28 The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation Growth inhibiting agent and the use thereof
IE64346B1 (en) * 1988-01-19 1995-07-26 Moses Judah Folkman Growth inhibiting agent and the use thereof
US5760015A (en) * 1988-01-19 1998-06-02 The Trustees Of The University Of Pennsylvania Cyclodextrin compounds and methods of making and use thereof
AU626538B2 (en) * 1988-01-19 1992-08-06 Moses Judah Folkman Growth inhibiting agent and the use thereof
DE3809808A1 (en) * 1988-03-23 1989-10-05 Hexal Pharma Gmbh & Co Kg SOLIDS, ESPECIALLY FESTORAL AND RECTAL, ETOFENAMATE-CONTAINING MEDICINAL PRODUCTS
US5236944A (en) * 1988-03-28 1993-08-17 Janssen Pharmaceutica N.V. Compounds, compositions and anti-neoplastic methods
DE3815902A1 (en) * 1988-05-10 1989-11-23 Schwarz Pharma Gmbh Inclusion compounds of 1-(4-(2-(5-chloro-2-methoxybenzamido)ethyl)phenylsulphonyl)-3-cyclohex ylurea with alpha -, beta - and gamma -cyclodextrins, a pharmaceutical product containing these in each case, and process for the production thereof
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
NL8801670A (en) 1988-07-01 1990-02-01 Walter Adrianus Josephus Johan PHARMACEUTICAL PREPARATION.
EP0381747A4 (en) * 1988-08-15 1991-09-11 American Maize-Products Company Water soluble branched beta cyclodextrin steroid complex
US5229370A (en) * 1988-08-15 1993-07-20 Ammeraal Robert N Water soluble branched beta cyclodextrin steroid complex
MY106598A (en) * 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.
US5997856A (en) * 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
JP2929108B2 (en) * 1988-10-28 1999-08-03 株式会社資生堂 Cosmetics and powder cosmetics
AU616571B2 (en) * 1988-10-28 1991-10-31 Shiseido Company Ltd. Cosmetic composition containing inclusion product with hydroxyalkylated cyclodextrin
IT1227626B (en) * 1988-11-28 1991-04-23 Vectorpharma Int SUPPORTED DRUGS WITH INCREASED DISSOLUTION SPEED AND PROCEDURE FOR THEIR PREPARATION
US5441944A (en) * 1989-04-23 1995-08-15 The Trustees Of The University Of Pennsylvania Substituted cyclodextrin sulfates and their uses as growth modulating agents
GB8910069D0 (en) * 1989-05-03 1989-06-21 Janssen Pharmaceutica Nv Method of topically treating acne vulgaris
JPH0737390B2 (en) * 1989-08-29 1995-04-26 久光製薬株式会社 Ointment composition
EP0491812A4 (en) * 1989-09-14 1992-11-04 Australian Commercial Research & Development Limited Drug delivery compositions
US5053240A (en) * 1989-10-24 1991-10-01 Kalamazoo Holdings, Inc. Norbixin adducts with water-soluble or water-dispersible proteins or branched-chain or cyclic polysaccharides
GB9001987D0 (en) * 1990-01-29 1990-03-28 Janssen Pharmaceutica Nv Improved cyclodextrin based erythropietin formulation
EP0518930A4 (en) * 1990-03-02 1993-09-15 Australian Commercial Research & Development Limited Cyclodextrin compositions and methods for pharmaceutical and industrial applications
FR2660309B1 (en) * 1990-03-27 1992-07-17 Roussel Uclaf NEW TIAPROFENIC ACID COMPLEXES OR ITS INSOLUBLE OR PARTIALLY SOLUBLE ESTERS WITH CYCLODEXTRINS OR DERIVATIVES THEREOF.
JP2867162B2 (en) * 1990-03-31 1999-03-08 株式会社資生堂 Peel-off type pack cosmetics
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5120720A (en) * 1990-09-20 1992-06-09 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Preparation of lipophile:hydroxypropylcyclodextrin complexes by a method using co-solubilizers
LU87843A1 (en) * 1990-11-15 1992-08-25 Cird Galderma AQUEOUS GEL BASED ON RETINOIC ACID AND HYDROXYPROPYL-BETA-CYCLODEXTRIN AND ITS USE IN HUMAN MEDICINE AND COSMETICS
JPH04351603A (en) * 1991-05-29 1992-12-07 Toppan Printing Co Ltd Cyclodextrin derivative
EP1004318A3 (en) * 1991-06-21 2002-08-07 Takeda Chemical Industries, Ltd. Cyclodextrin composition
US5446030A (en) * 1991-09-19 1995-08-29 Weisz; Paul B. Prevention of hemolysis
NZ244735A (en) * 1991-10-16 1995-12-21 Schering Corp Pharmaceutical compositions containing a lipophilic oligosaccharide antibiotic salt
IL103558A0 (en) 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
US5254541A (en) * 1991-11-15 1993-10-19 Merck Frosst Canada, Inc. (Quinolin-2-ylmethoxy)indole/cyclodextrin complex
DE4207922A1 (en) * 1992-03-13 1993-09-23 Pharmatech Gmbh New water-soluble inclusion complexes contg randomly substd. methyl-beta-cyclodextrin - for admin. of substances which are only sparingly soluble in water
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
DE4227569C1 (en) * 1992-08-20 1994-06-09 Inst Chemo Biosensorik Enzymatic determn. of inorganic phosphate - using combination of di:saccharide phosphorylase, phosphatase or maltose synthase, and glucose oxido-reductase
TW251236B (en) * 1992-09-10 1995-07-11 Ciba Vision Ag
JP2879395B2 (en) * 1992-10-26 1999-04-05 富士写真フイルム株式会社 Anticancer composition containing rhodacyanine compound and cyclodextrin
US5494901A (en) * 1993-01-05 1996-02-27 Javitt; Jonathan C. Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent
RU2143896C1 (en) * 1993-03-05 2000-01-10 Хексаль Аг Crystalline complex of cyclodextrin with ranitidin hydrochloride, method of preparation thereof, and pharmaceutical compositions containing thereof
WO1994022455A1 (en) * 1993-03-31 1994-10-13 The Trustees Of The University Of Pennsylvania Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor
DK94093D0 (en) * 1993-08-17 1993-08-17 Finn Molke Borgbjerg LOCAL ANAESTHETIC PREPARATION
TW349870B (en) * 1993-09-30 1999-01-11 Janssen Pharmaceutica Nv An antifungal pharmaceutical composition for oral administration and a process for the preparation thereof
RU2135176C1 (en) * 1993-12-14 1999-08-27 Эли Лилли Энд Компани Water-dissolved inclusion complex of benzothiophene compounds with water-soluble cyclodextrin, method of synthesis and pharmaceutical composition
US5646131A (en) * 1994-02-22 1997-07-08 The Arab Company For Drug Industries And Medical Applicances (Acdima) Method for solubilizing drugs using cyclodextrins and carboxylic acids
AU1716995A (en) * 1994-03-18 1995-10-09 Ciba-Geigy Ag Aqueous solution of levocabastine for ophthalmic use
DE4414138A1 (en) * 1994-04-22 1995-10-26 Consortium Elektrochem Ind Acylated gamma cyclodextrins
BR9507768A (en) * 1994-05-27 1997-09-02 Farmarc Nederland Bv Pharmaceutical composition
FR2726765B1 (en) * 1994-11-14 1996-12-20 Cis Bio Int RADIOPHARMACEUTICAL COMPOSITIONS COMPRISING A COMPLEX INCLUDING A CYCLODEXTRIN AND A RADIOHALOGEN FATTY ACID
US5576311A (en) * 1994-11-30 1996-11-19 Pharmos Corporation Cyclodextrins as suspending agents for pharmaceutical suspensions
FR2735136B1 (en) * 1995-06-08 1997-08-14 Roquette Freres PULVERULENT COMPOSITION OF HYDROXYPROPYL-BETACYCLODEXTRIN AND ITS PREPARATION PROCESS.
JP2920611B2 (en) * 1995-12-11 1999-07-19 株式会社シーエーシー Topical treatment for dermatitis
GB9605705D0 (en) 1996-03-19 1996-05-22 Pfizer Ltd Therapeutic agents
ATE298582T1 (en) 1996-04-19 2005-07-15 Alpha Therapeutic Corp METHOD FOR INACTIVATION OF VIRUSES AND LYOPHILIZATION OF BLOOD PROTEINS
SE9601556D0 (en) * 1996-04-24 1996-04-24 Astra Ab New pharmaceutical formulation of a thrombin inhibitor for parenteral use
AU709580B2 (en) * 1996-08-09 1999-09-02 Alcon Laboratories, Inc. Preservative systems for pharmaceutical compositions containing cyclodextrins
US5942501A (en) * 1996-08-16 1999-08-24 Collaborative Laboratories, Inc. Cyclodextrin derivative complex
EP0838225A3 (en) * 1996-10-25 1999-03-24 Hiji, Yasutake Aqueous local anesthetic solution
SI0969821T1 (en) * 1997-03-26 2003-10-31 Janssen Pharmaceutica N.V. Pellets having a core coated with an antifungal and a polymer
GB9713149D0 (en) 1997-06-21 1997-08-27 Pfizer Ltd Pharmaceutical formulations
KR20010031520A (en) 1997-11-07 2001-04-16 스즈키 다다시 Piperazine-Cyclodextrin Complex
ES2185238T3 (en) 1997-12-31 2003-04-16 Choongwae Pharma Corp ORAL PREPARATION OF ITRACONAZOL AND ITS PREPARATION PROCEDURE.
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
DE19848303A1 (en) * 1998-10-14 2000-04-20 Schering Ag Stable combination of 14,17-over-bridged steroid gestagen and cyclodextrin compound, useful for treating climacteric disorders or for contraception
GB9906126D0 (en) * 1999-03-18 1999-05-12 Knoll Ag Pharmaceutical formulations
WO2001001955A1 (en) * 1999-07-02 2001-01-11 Janssen Pharmaceutica N.V. Nasal formulation of an antifungal
SE9902988D0 (en) * 1999-08-24 1999-08-24 Astra Ab Chemical compounds
SI1278549T1 (en) 2000-05-02 2009-04-30 Theravance Inc Composition containing a cyclodextrin and a glycopeptide antibiotic
US6468989B1 (en) 2000-07-13 2002-10-22 Dow Pharmaceutical Sciences Gel compositions containing metronidazole
PE20020300A1 (en) 2000-08-22 2002-05-10 Pharmacia Corp COMPOSITION OF SOLUTION OF AN ANTIBIOTIC DRUG BASED ON OXAZOLIDINONE WITH IMPROVEMENT OF DRUG LOAD
US7074824B2 (en) 2001-07-31 2006-07-11 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
US6962944B2 (en) 2001-07-31 2005-11-08 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
US6982256B2 (en) 2001-09-07 2006-01-03 Boehringer Ingelheim Pharma Kg Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration
CA2463687A1 (en) 2001-10-18 2003-04-24 Decode Genetics Ehf Cyclodextrin complexes
GB0127677D0 (en) * 2001-11-19 2002-01-09 Vianex S A Inclusion complex
US6881726B2 (en) 2001-12-24 2005-04-19 Dow Pharmaceutical Sciences Aqueous compositions containing metronidazole
AR038575A1 (en) 2002-02-22 2005-01-19 Pharmacia Corp OPHTHALM FORMULATION WITH NEW RUBBER COMPOSITION
US6951846B2 (en) * 2002-03-07 2005-10-04 The United States Of America As Represented By The Secretary Of The Army Artemisinins with improved stability and bioavailability for therapeutic drug development and application
US6818662B2 (en) 2002-05-28 2004-11-16 Taisho Pharmaceutical Co., Ltd. Pharmaceutical composition
DE10228049A1 (en) * 2002-06-24 2004-01-15 Merck Patent Gmbh Liquid preparation containing oligopeptides
BR122018068797B1 (en) 2003-03-28 2021-04-27 Ares Trading S.A. PHARMACEUTICAL COMPOSITIONS OF COMPLEX CYCLODEXTRIN-CLADRIBINE COMPLEX, USES OF THE COMPLEX, AS WELL AS PROCESSES FOR ITS PREPARATION
CA2520522C (en) 2003-03-28 2012-05-29 Ivax Corporation Cladribine formulations for improved oral and transmucosal delivery
UA81305C2 (en) 2003-07-02 2007-12-25 Ares Trading Sa Formulation of cladribine (variants), cladribine-cyclodextrin complex, use of cladribine-cyclodextrin complex, mixture
CN1294912C (en) * 2004-03-01 2007-01-17 上海医药工业研究院 Itraconazole hydrochloride composition and freeze-dried powder injection thereof
DE102004011512B4 (en) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing pimobendan
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
ITMI20041763A1 (en) * 2004-09-16 2004-12-16 Altergon Sa NEW INJECTABLE FORMULATIONS CONTAINING PROGESTERONE
WO2006137433A1 (en) * 2005-06-21 2006-12-28 Wakamoto Pharmaceutical Co., Ltd. Aqueous preparation having levocabastine solubilized therein
US7744904B1 (en) 2005-09-26 2010-06-29 B.B. Scientific L.L.C. Stabilization of Clostridium botulinum neurotoxin complex
CN101516339B (en) 2006-08-16 2012-06-13 诺瓦提斯公司 Method for making solid dispersions of highly crystalline therapeutic compounds
UA95310C2 (en) * 2006-10-20 2011-07-25 Айкос Корпорейшен Composition containing chkl inhibitor and cyclodextrin for the treatment of cancer
EP1920785A1 (en) * 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
US20100056500A1 (en) * 2006-11-21 2010-03-04 Thitiwan Buranachokaisan Stable Parenteral Formulation
BRPI0908077A2 (en) * 2008-02-28 2015-08-25 Takeda Pharmaceutical Pharmaceutical composition, methods for preventing or treating disease, and for improving water solubility of a compound, salt or prodrug thereof
NZ592927A (en) 2008-11-25 2013-07-26 Boehringer Ingelheim Vetmed PHOSPHODIESTERASE TYPE III (PDE III) INHIBITORS OR CA2+-SENSITIZING AGENTS such as pimobendan FOR THE TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY
WO2010088924A1 (en) 2009-02-06 2010-08-12 Telormedix Sa Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
CN102499909B (en) * 2011-12-27 2013-08-07 哈尔滨三联药业有限公司 Itraconazole dispersible tablets and preparation method thereof
KR101383941B1 (en) * 2012-03-09 2014-04-10 동아에스티 주식회사 Stable pharmaceutical composition containing piroxicam or its pharmaceutical acceptable salt and hyaluronic acid and its pharmaceutical acceptable salt and their manufacturing method thereof
EP2825159B1 (en) 2012-03-15 2022-06-22 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
SG11201408565VA (en) * 2012-06-28 2015-02-27 Mcneil Ppc Inc Racecadotril liquid compositions
MX2015011367A (en) * 2013-03-13 2015-12-16 Seattle Genetics Inc Cyclodextrin and antibody-drug conjugate formulations.
ES2860526T3 (en) 2013-07-19 2021-10-05 Boehringer Ingelheim Vetmedica Gmbh Preserved Etherified Cyclodextrin Derivatives Containing A Liquid Aqueous Pharmaceutical Composition
JP2016532660A (en) * 2013-10-08 2016-10-20 イノファーマ インク Aprepitant oral liquid formulation
PL2925305T3 (en) 2013-12-04 2017-07-31 Boehringer Ingelheim Vetmedica Gmbh Improved pharmaceutical compositions of pimobendan
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
PL3644999T3 (en) * 2017-06-30 2023-05-08 Celgene Corporation Compositions and methods of use of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl) methyl) -2,2-difluoroacetamide
US10716774B1 (en) 2018-01-05 2020-07-21 Yale Pharmaceuticals LLC Pharmaceutical compositions containing isotretinoin with improved dissolution profile and enhanced stability
JP2021529243A (en) * 2018-06-29 2021-10-28 ロケット フレールＲｏｑｕｅｔｔｅ Ｆｒｅｒｅｓ A novel hydroxypropyl-β-cyclodextrin and a method for producing it
FR3083234B1 (en) * 2018-06-29 2020-11-27 Roquette Freres NEW HYDROXYPROPYL-BETA-CYCLODEXTRINS AND THEIR PREPARATION METHODS
JP7446322B2 (en) 2018-10-29 2024-03-08 シクロ セラピューティクス インク How to treat Alzheimer's disease
CN114195733A (en) * 2022-01-07 2022-03-18 华东理工大学 Method for inhibiting isomerization of probenazole

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459731A (en) * 1966-12-16 1969-08-05 Corn Products Co Cyclodextrin polyethers and their production
US3453259A (en) * 1967-03-22 1969-07-01 Corn Products Co Cyclodextrin polyol ethers and their oxidation products
HU181703B (en) * 1980-05-09 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents
US4371673A (en) * 1980-07-21 1983-02-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble forms of retinoids

Also Published As

Publication number Publication date
DK175288B1 (en) 2004-08-09
CY1689A (en) 1994-01-14
HU200943B (en) 1990-09-28
SG24893G (en) 1993-08-06
FI853198L (en) 1985-08-20
EP0149197A3 (en) 1985-08-14
FI853198A0 (en) 1985-08-20
EP0149197B1 (en) 1990-03-21
DK359585A (en) 1985-08-07
LU90283I2 (en) 1998-11-03
DK359585D0 (en) 1985-08-07
CA1222697A (en) 1987-06-09
FI86140C (en) 1992-07-27
AU3835285A (en) 1985-07-12
ATE51145T1 (en) 1990-04-15
JPS61500788A (en) 1986-04-24
ZA8410042B (en) 1985-09-25
HUT40561A (en) 1987-01-28
FI86140B (en) 1992-04-15
EP0149197B2 (en) 1997-01-08
WO1985002767A1 (en) 1985-07-04
NL980009I1 (en) 1998-05-06
DE3346123A1 (en) 1985-06-27
AU565966B2 (en) 1987-10-01
NO2000007I1 (en) 2000-09-21
DE3481680D1 (en) 1990-04-26
EP0149197A2 (en) 1985-07-24
JPH0570612B2 (en) 1993-10-05

Similar Documents

Publication Publication Date Title
SG24893G (en) Pharmaceutical compositions containing drugs which are sparingly soluble in water or instable and methods for their preparation
IL89503A0 (en) Taxol derivatives,pharmaceutical compositions containing the same and process for the preparation thereof
IL77133A (en) Antineoplastic pharmaceutical compositions containing pentofuranoside derivatives,some new such compounds and their preparation
IL72854A (en) 1-heteroaryl-4-((2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives,their preparation and pharmaceutical compositions containing them
IL88765A (en) N-hydroxycycloalkyl or n-hydroxycycloalkenyl- substituted adenosine derivatives, methods for their preparation and pharmaceutical compositions, including antilipolytic compositions, containing the same
IL73756A (en) 5-sulfamoylalkyl-3-aminoalkyl indole derivatives,their preparation and pharmaceutical compositions containing them
IL71249A0 (en) Thiazolidine derivatives,their preparation and pharmaceutical compositions containing them
IL66434A0 (en) Thiazolidinylalkylene piperazine derivatives,their preparation and pharmaceutical compositions containing them
DE3886298T2 (en) Aralkylamine alkoxyphenyl derivatives, process for their preparation and compositions containing them.
DE3485318D1 (en) OXOPYRIMIDINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
IL68011A0 (en) Cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
SE8302979L (en) PIPERAZINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE
IL62229A0 (en) Heterocyclic derivatives,their preparation and pharmaceutical compositions containing them
IL73902A (en) Gonadoliberin derivatives,their preparation and pharmaceutical compositions containing them
DE3060669D1 (en) Phenylalanyl-tryptophan derivatives, pharmaceutical compositions containing them, their preparation and use
IL66433A (en) Spirothiazolidinyl piperazine derivatives,their preparation and pharmaceutical compositions containing them
IL72480A (en) Benzamidine derivatives,their preparation and pharmaceutical compositions containing them
IL84665A0 (en) Azole derivatives,their preparation and pharmaceutical compositions containing them
DK0457215T3 (en) 3-deamino-4-deoxy-4-amino-8-fluoroanthracyclines and methods for their preparation
IL61861A0 (en) Rifamycin derivatives,their preparation and pharmaceutical compositions containing them
IL87975A (en) Cephalosporin derivatives, their preparation and pharmaceutical compositions containing them
IL84129A (en) Bis(2,2-dialkylalkanoyl)-3-(4-trialkylbenzyl)-1-piperazinyl)-rifamycin s derivatives,their preparation and pharmaceutical compositions containing them
IL66812A0 (en) Cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
IL84283A0 (en) Cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
IL70468A0 (en) Tetrahydropyrimidine derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20041219